Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Mancini

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Psychiatry|November 26, 2002
Topiramate treatment for SSRI-induced weight gain in anxiety disordersMichael Van Ameringen, Catherine Mancini, Beth Pipe, et al.
The Journal of Clinical Psychiatry|January 12, 2005
An open trial of topiramate in the treatment of generalized social phobiaMichael Van Ameringen, Catherine Mancini, Beth Pipe, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomaniaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Journal of Anxiety Disorders|June 27, 2003
Quality of life and the anxiety disordersLena C Quilty, Michael Van Ameringen, Catherine Mancini, et al.
The Journal of Clinical Psychiatry|March 6, 2007
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trialMichael Van Ameringen, Catherine Mancini, Jonathan Oakman, et al.
Psychiatry Research|November 18, 2004
A PET provocation study of generalized social phobiaMichael Van Ameringen, Catherine Mancini, Henry Szechtman, et al.
Depression and Anxiety|September 15, 2009
Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorderNaomi M Simon, Nannette N Herlands, Elizabeth H Marks, et al.
Cancer Cell|August 19, 2007
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myelomaJonathan J Keats, Rafael Fonseca, Marta Chesi, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Psychiatry|November 26, 2002
Topiramate treatment for SSRI-induced weight gain in anxiety disordersMichael Van Ameringen, Catherine Mancini, Beth Pipe, et al.
The Journal of Clinical Psychiatry|January 12, 2005
An open trial of topiramate in the treatment of generalized social phobiaMichael Van Ameringen, Catherine Mancini, Beth Pipe, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomaniaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Journal of Anxiety Disorders|June 27, 2003
Quality of life and the anxiety disordersLena C Quilty, Michael Van Ameringen, Catherine Mancini, et al.
The Journal of Clinical Psychiatry|March 6, 2007
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trialMichael Van Ameringen, Catherine Mancini, Jonathan Oakman, et al.
Psychiatry Research|November 18, 2004
A PET provocation study of generalized social phobiaMichael Van Ameringen, Catherine Mancini, Henry Szechtman, et al.
Depression and Anxiety|September 15, 2009
Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorderNaomi M Simon, Nannette N Herlands, Elizabeth H Marks, et al.
Cancer Cell|August 19, 2007
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myelomaJonathan J Keats, Rafael Fonseca, Marta Chesi, et al.
Pageof 3